Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 94

1.

Human lipooligosaccharide IGG that prevents endemic meningococcal disease recognizes an internal lacto-N-neotetraose structure.

Cheng H, Yang Z, Estabrook MM, John CM, Jarvis GA, McLaughlin S, Griffiss JM.

J Biol Chem. 2011 Dec 23;286(51):43622-33. doi: 10.1074/jbc.M111.291583. Epub 2011 Oct 25.

PMID:
22027827
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Affinity-purified human immunoglobulin G that binds a lacto-N-neotetraose-dependent lipooligosaccharide structure is bactericidal for serogroup B Neisseria meningitidis.

Estabrook MM, Jarvis GA, McLeod Griffiss J.

Infect Immun. 2007 Feb;75(2):1025-33. Epub 2006 Nov 13.

PMID:
17101655
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

The lipooligosaccharide (LOS) of Neisseria meningitidis serogroup B strain NMB contains L2, L3, and novel oligosaccharides, and lacks the lipid-A 4'-phosphate substituent.

Rahman MM, Stephens DS, Kahler CM, Glushka J, Carlson RW.

Carbohydr Res. 1998 Feb;307(3-4):311-24.

PMID:
9675370
[PubMed - indexed for MEDLINE]
4.
5.
7.
8.
9.

The fine structure of Neisseria meningitidis lipooligosaccharide from the M986 strain and three of its variants.

Tsai CM, Jankowska-Stephens E, Mizanur RM, Cipollo JF.

J Biol Chem. 2009 Feb 13;284(7):4616-25. doi: 10.1074/jbc.M808209200. Epub 2008 Dec 17.

PMID:
19095648
[PubMed - indexed for MEDLINE]
Free Article
10.

Characterization of terminal NeuNAcalpha2-3Galbeta1-4GlcNAc sequence in lipooligosaccharides of Neisseria meningitidis.

Tsai CM, Chen WH, Balakonis PA.

Glycobiology. 1998 Apr;8(4):359-65.

PMID:
9499383
[PubMed - indexed for MEDLINE]
Free Article
11.

The MisR/MisS two-component regulatory system influences inner core structure and immunotype of lipooligosaccharide in Neisseria meningitidis.

Tzeng YL, Datta A, Ambrose K, Lo M, Davies JK, Carlson RW, Stephens DS, Kahler CM.

J Biol Chem. 2004 Aug 13;279(33):35053-62. Epub 2004 Jun 1.

PMID:
15173178
[PubMed - indexed for MEDLINE]
Free Article
12.

Enhanced factor H binding to sialylated Gonococci is restricted to the sialylated lacto-N-neotetraose lipooligosaccharide species: implications for serum resistance and evidence for a bifunctional lipooligosaccharide sialyltransferase in Gonococci.

Gulati S, Cox A, Lewis LA, Michael FS, Li J, Boden R, Ram S, Rice PA.

Infect Immun. 2005 Nov;73(11):7390-7. Erratum in: Infect Immun. 2006 Apr;74(4):2503.

PMID:
16239538
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Preparation, characterization, and immunogenicity of meningococcal immunotype L2 and L3,7,9 phosphoethanolamine group-containing oligosaccharide-protein conjugates.

Verheul AF, Braat AK, Leenhouts JM, Hoogerhout P, Poolman JT, Snippe H, Verhoef J.

Infect Immun. 1991 Mar;59(3):843-51.

PMID:
1900063
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Factor H binding and function in sialylated pathogenic neisseriae is influenced by gonococcal, but not meningococcal, porin.

Madico G, Ngampasutadol J, Gulati S, Vogel U, Rice PA, Ram S.

J Immunol. 2007 Apr 1;178(7):4489-97.

PMID:
17372007
[PubMed - indexed for MEDLINE]
Free Article
16.

Neisserial lipooligosaccharide is a target for complement component C4b. Inner core phosphoethanolamine residues define C4b linkage specificity.

Ram S, Cox AD, Wright JC, Vogel U, Getzlaff S, Boden R, Li J, Plested JS, Meri S, Gulati S, Stein DC, Richards JC, Moxon ER, Rice PA.

J Biol Chem. 2003 Dec 19;278(51):50853-62. Epub 2003 Oct 2.

PMID:
14525973
[PubMed - indexed for MEDLINE]
Free Article
17.

Structure of an alpha-2,6-sialylated lipooligosaccharide from Neisseria meningitidis immunotype L1.

Wakarchuk WW, Gilbert M, Martin A, Wu Y, Brisson JR, Thibault P, Richards JC.

Eur J Biochem. 1998 Jun 15;254(3):626-33.

PMID:
9688275
[PubMed - indexed for MEDLINE]
Free Article
18.
19.

Genetically modified L3,7 and L2 lipooligosaccharides from Neisseria meningitidis serogroup B confer a broad cross-bactericidal response.

Weynants V, Denoƫl P, Devos N, Janssens D, Feron C, Goraj K, Momin P, Monnom D, Tans C, Vandercammen A, Wauters F, Poolman JT.

Infect Immun. 2009 May;77(5):2084-93. doi: 10.1128/IAI.01108-08. Epub 2009 Mar 16.

PMID:
19289516
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

The meningococcal vaccine candidate neisserial surface protein A (NspA) binds to factor H and enhances meningococcal resistance to complement.

Lewis LA, Ngampasutadol J, Wallace R, Reid JE, Vogel U, Ram S.

PLoS Pathog. 2010 Jul 29;6(7):e1001027. doi: 10.1371/journal.ppat.1001027.

PMID:
20686663
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk